Utilization of Oral Hypoglycemic Agents in a Drug-Insured U.S. Population
نویسندگان
چکیده
منابع مشابه
Utilization of oral hypoglycemic agents in a drug-insured U.S. population.
OBJECTIVE Clinical trials provide information regarding the safety and efficacy of medications used to manage type 2 diabetes but do not elucidate drug effectiveness in a typical managed care environment. The aim of this study was to characterize "real-world" drug utilization patterns from both a prescriber and a patient perspective. RESEARCH DESIGN AND METHODS We conducted a retrospective an...
متن کاملA Study on Drug Utilization of Oral Hypoglycemic Agents in Type-2 Diabetic Patients
Objective: To evaluate drug utilization pattern of oral hypoglycemic agents in Type-2 diabetic outpatients. Materials and Methods: A prospective study was carried out in 202 out patients for a period of 9 months in a tertiary care hospital. Patients treated with oral hypoglycemic agents were used for the study. The demographic data, disease data and utilization of different classes of oral hypo...
متن کاملAdherence to Oral Hypoglycemic Agents in Hawaii
INTRODUCTION Adherence to oral hypoglycemic agents is essential to reducing the poor health outcomes of populations at high risk for developing diabetes and its chronic complications. The goal of this study was to identify characteristics of patients in Hawaii least likely to adhere to oral hypoglycemic agents. METHODS This retrospective administrative data analysis included prescription refi...
متن کاملOral Hypoglycemic Agents in pregnancy: An Update.
INTRODUCTION Traditionally, insulin has been the gold standard in the management of Type 2 diabetes in pregnancy and gestational diabetes. However, insulin therapy can be inconvenient because of the needs for multiple injections, its associated cost, pain at the injection site, need for refrigeration, and skillful handling of the syringes. This has led to the exploration of oral hypoglycemic ag...
متن کاملThe use of oral hypoglycemic agents.
This DESG Teaching Letter was written by the DESG Executive commitee: Executive commitee: Dr. J.M. BOAVIDA, MD, Lisbon – Portugal (President); Dr. A. BROOKS, MD, Winchester – UK (Vice-President); Dr. I. HARMAN-BOEHM, MD, Sheva – Israel. (Director Educational Strategies); Ms. D. VARAKLA, Athens – Greece (Honorary Secretary); Dr. A. BALDELLI, MD, Rome – Italy (Honorary Treasurer); Dr. R. CHLUP, M...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Diabetes Care
سال: 2001
ISSN: 0149-5992,1935-5548
DOI: 10.2337/diacare.24.8.1411